XT
XFOR icon

XTX Topco’s X4 Pharmaceuticals XFOR Stock Holding History

XTX Topco’s Portfolio XFOR Stock Details XFOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,927
Closed -$13.7K – 3273
2025
Q1 		$13.7K Buy
+1,927
New +$26.5K ﹤0.01% 2207
2024
Q4 		– Sell
-5,255
Closed -$106K – 3012
2024
Q3 		$106K Buy
5,255
+1,547
+42% +$32.3K 0.01% 1597
2024
Q2 		$64.5K Buy
+3,708
New +$121K 0.01% 1479
2024
Q1 		– Sell
-2,303
Closed -$57.9K – 2393
2023
Q4 		$57.9K Buy
+2,303
New +$56K 0.01% 1210
2023
Q2 		– Sell
-3,222
Closed -$84.1K – 1906
2023
Q1 		$84.1K Buy
+3,222
New +$94.5K 0.02% 1118
2022
Q2 		– Sell
-885
Closed -$46K – 1144
2022
Q1 		$46K Buy
885
+220
+33% +$12.6K 0.02% 598
2021
Q4 		$46K Buy
+665
New +$84.1K 0.03% 574

Other funds holding XFOR

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

XTX Topco's XFOR Position: Q2 2025 in Review

XTX Topco sold out of X4 Pharmaceuticals (XFOR) in Q2 2025, closing a stake of 1,927 shares — an estimated $13.7K sold.

XTX Topco first reported a position in XFOR in Q4 2021 and held it in 7 quarters. The position peaked at $106K in Q3 2024. 51 funds tracked by Wall St. Rank hold XFOR as of Q2 2025.

  • XTX Topco reported no remaining X4 Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
  • XTX Topco sold 1,927 X4 Pharmaceuticals shares in Q2 2025, an estimated $13.7K.
  • XTX Topco first reported a position in X4 Pharmaceuticals in Q4 2021 and held it in 7 quarters.
  • XTX Topco's X4 Pharmaceuticals position peaked at $106K in Q3 2024.
  • 51 funds tracked by Wall St. Rank held X4 Pharmaceuticals as of Q2 2025.

Based on XTX Topco's 13F filing for Q2 2025, filed 12 Aug 2025.